The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Wyeth Pharmaceuticals
Huntercombe Lane South, Taplow, Maidenhead, Berks, SL6 0PH
Telephone: +44 (0)1628 604 377
Fax: +44 (0)1628 666 368
Medical Information Direct Line: +44 (0)845 367 0098
Medical Information e-mail: ukmedinfo@wyeth.com
Medical Information Fax: +44 (0)845 367 0777
Need to contact this company?
Patient Information Leaflet last updated on the eMC: 29/07/2009
PIL Enbrel 25 mg powder and solvent for solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/07/2009 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 10/06/2009 and displayed until 29/07/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 09/04/2009 and displayed until 10/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 28/01/2009 and displayed until 09/04/2009
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 10/12/2008 and displayed until 28/01/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 29/07/2008 and displayed until 10/12/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to drug interactions
  • Change to date of revision
  • Change to side-effects
Updated on 12/12/2007 and displayed until 29/07/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 25/09/2007 and displayed until 12/12/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Further Information section
  • Change to how to administer the medicine
Updated on 01/02/2007 and displayed until 25/09/2007
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 19/12/2006 and displayed until 01/02/2007
Reasons for adding or updating:
  • Change to how to administer the medicine
Updated on 16/11/2006 and displayed until 19/12/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to Further Information section
  • Change to date of revision
Updated on 10/07/2006 and displayed until 16/11/2006
Reasons for adding or updating:
  • Change to how to administer the medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 21/09/2005 and displayed until 10/07/2006
Reasons for adding or updating:
  • Change of manufacturer
  • Change to how the medicine works
Updated on 09/05/2005 and displayed until 21/09/2005
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to information about driving or using machinery
  • Change to storage instructions
  • Change to Further Information section
  • Change to how to administer the medicine
Updated on 04/11/2004 and displayed until 09/05/2005
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to drug interactions
Updated on 23/09/2004 and displayed until 04/11/2004
Reasons for adding or updating:
  • Change to side-effects
  • Change to how to administer the medicine
Updated on 03/06/2004 and displayed until 23/09/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  etanercept


Return to the top of the page

© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk